Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
企業コードHLN
会社名Haleon PLC
上場日Jul 18, 2022
設立日2021
最高経営責任者「CEO」Mr. Brian Mcnamara
従業員数- -
証券種類Ordinary Share
決算期末Jul 18
本社所在地Building 5, First Floor
都市WEYBRIDGE
証券取引所London Stock Exchange
国United Kingdom
郵便番号KT13 0NY
電話番号441932822000
ウェブサイトhttps://www.haleon.com/
企業コードHLN
上場日Jul 18, 2022
設立日2021
過去5年間の配当金総支払額は
0.00
米ドルである。
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023